The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of gemcitabine and trastuzumab in HER2-directed therapy pretreated patients with HER2-positive metastatic breast cancer: SBP-01 study.
 
Seiji Yoshitomi
No Relationships to Disclose
 
Hisashi Tsuji
No Relationships to Disclose
 
Masahiko Ikeda
No Relationships to Disclose
 
Mitsuya Ito
No Relationships to Disclose
 
Shoichiro Ohtani
No Relationships to Disclose
 
Kenji Higaki
No Relationships to Disclose
 
Teiri Sagawa
No Relationships to Disclose
 
Kinya Matsuoka
No Relationships to Disclose
 
Hiroshi Kawai
No Relationships to Disclose
 
Daisuke Takabatake
No Relationships to Disclose
 
Hiroyoshi Doihara
No Relationships to Disclose
 
Tadahiko Shien
No Relationships to Disclose
 
Naruto Taira
No Relationships to Disclose
 
Yasuyuki Ohtawa
No Relationships to Disclose
 
Shuichiro Maruyama
No Relationships to Disclose
 
Hajime Hikino
No Relationships to Disclose
 
Sayaka Fujii
No Relationships to Disclose
 
Yutaka Yamamoto
No Relationships to Disclose
 
Shozo Ohsumi
No Relationships to Disclose
 
Fumikata Hara
Research Funding - Chugai Pharma; Eisai